Back to User profile » Dr Xueyan Zhang

Papers published by Dr Xueyan Zhang:


Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery

Lu J, Lou Y, Zhang Y, Zhong R, Zhang W, Zhang X, Wang H, Chu T, Han B, Zhong H

International Journal of Nanomedicine 2023, 18:263-276

Published Date: 13 January 2023

Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study

Qian J, Zhang X, Zhang B, Yan B, Wang L, Gu P, Wang W, Wang H, Han B

Cancer Management and Research 2020, 12:3293-3299

Published Date: 11 May 2020

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China

Xu J, Ding G, Zhang X, Jin B, Lou Y, Zhang Y, Wang H, Wu D, Han B

OncoTargets and Therapy 2016, 9:6479-6484

Published Date: 20 October 2016